Production (Stage)
Ginkgo Bioworks Holdings, Inc.
DNA
$7.42
$0.639.28%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -90.96M | -107.53M | -56.40M | -217.18M | -165.91M |
| Total Depreciation and Amortization | 15.37M | 15.65M | 17.17M | 17.33M | 12.87M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.64M | 47.27M | 33.77M | 109.58M | 63.47M |
| Change in Net Operating Assets | -11.57M | 2.18M | -98.04M | 5.88M | 312.00K |
| Cash from Operations | -51.52M | -42.44M | -103.50M | -84.39M | -89.26M |
| Capital Expenditure | -7.62M | -13.71M | -15.09M | -27.03M | -6.71M |
| Sale of Property, Plant, and Equipment | -- | 57.00K | 400.00K | 191.00K | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | -5.40M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -191.06M | 568.00K | 4.49M | -- | -- |
| Cash from Investing | -198.68M | -13.09M | -10.20M | -26.84M | -12.11M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -207.00K | -203.00K | -200.00K | -200.00K | -294.00K |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 14.00K | 70.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -265.00K | -40.00K | -621.00K |
| Cash from Financing | -207.00K | -203.00K | -465.00K | -226.00K | -845.00K |
| Foreign Exchange rate Adjustments | 74.00K | -73.00K | -35.00K | -16.00K | -157.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -250.34M | -55.80M | -114.20M | -111.47M | -102.37M |